Please login to the form below

Not currently logged in
Email:
Password:

Researchers develop breath test for TB

Inhaled form of isoniazid could show almost instant results

TB vaccine

Researchers have developed the first breath test to diagnose tuberculosis (TB).

It uses an inhaled form of the antibiotic isoniazid that is activated by TB enzymes that are unique to the disease.

The researchers gave a molecularly-labelled form of isoniazid to laboratory rabbits - when TB was present, nitrogen gas was released from the lungs and detectable by a mass spectrometer.

The new breath test samples the whole lung's capacity and researchers hope results will be available almost immediately.

In 2010, the World Health Organization (WHO) recommended the use of a DNA detection technique called GeneXpert for TB diagnosis. From a sample of sputum, the method can detect whether TB is present and if it is resistant to rifampicin, a common treatment, within three hours.

TB infects 8.6m people worldwide every year and kills 1.3m, second only to HIV. Early diagnosis and treatment are crucial in the global fight against TB, according to the WHO.

Article by
Kirstie Pickering

26th September 2014

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Apex.co.uk Conferences, Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading event and exhibition agencies, specialising in healthcare. We understand your communication goals, whether...

Latest intelligence

Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...
Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...

Infographics